3 Australian AI Healthcare Stocks to Watch in September 2026

Artificial intelligence is increasingly becoming part of the healthcare industry, with applications ranging from medical imaging and diagnostics to clinical decision support and data management.
Australia is also attracting attention as a healthcare, medical research and technology market, creating opportunities for smaller ASX-listed companies developing AI-enabled healthcare solutions.
A recent Yahoo Finance article highlighted three Australian companies that investors may want to watch in September 2026: ImExHS (ASX: IME), Singular Health Group (ASX: SHG), and Artrya (ASX: AYA). These companies approach healthcare AI from different angles, but all are connected to the growing use of artificial intelligence in medical imaging and diagnostics.
However, these companies also demonstrate why investors need to look beyond the AI label. Smaller healthcare technology businesses can carry significant commercial, regulatory, funding, and execution risks.
This article explores the three companies with their AI healthcare focus and the factors investors may want to consider when assessing the sector.








